FDA Adds Strict Safety Warnings on Arthritis Drugs From Pfizer, AbbVie

The U.S. health regulator has added new “boxed warnings” to drugs from Pfizer and AbbVie that are part of a class of anti-inflammatory treatments called JAK inhibitors, citing risk of serious health issues and death in some patients, the drugmakers said on Friday. Read More